SX-RDS1

N/A

Report date: 2025/06/11 10:51:53
NME

Base Information

Drug NameSX-RDS1
Drug Alias NameATM antagonists (Serometrix)ataxia telangiectasia mutated protein antagonists (Serometrix)RDS1-L12SX-RDS1
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionSerine-protein kinase ATM inhibitorsAnticancer protein kinase inhibitorsRadiosensitizers
TargetsSerine-protein kinase ATM
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSerometrix LLC
China Registration ClassN/A

Develop Information

Active CompaniesSerometrix LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A